These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39149885)

  • 1. Loss of DNA glycosylases improves health and cognitive function in a C. elegans model of human tauopathy.
    Tiwari V; Buvarp E; Borbolis F; Puligilla C; Croteau DL; Palikaras K; Bohr VA
    Nucleic Acids Res; 2024 Oct; 52(18):10965-10985. PubMed ID: 39149885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
    Wang C; Saar V; Leung KL; Chen L; Wong G
    Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOP loss of function protects against tauopathy.
    Eck RJ; Kow RL; Black AH; Liachko NF; Kraemer BC
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2207250120. PubMed ID: 36574656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of mitochondrial homeostasis is an early event in a
    Palikaras K; Achanta K; Choi S; Akbari M; Bohr VA
    Aging (Albany NY); 2021 Nov; 13(21):23876-23894. PubMed ID: 34751671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
    Kow RL; Strovas TJ; McMillan PJ; Jacobi AM; Behlke MA; Saxton AD; Latimer CS; Keene CD; Kraemer BC
    Neurobiol Dis; 2021 Jan; 147():105148. PubMed ID: 33184027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum unfolded protein response transcriptional targets of XBP-1s mediate rescue from tauopathy.
    Waldherr SM; Han M; Saxton AD; Vadset TA; McMillan PJ; Wheeler JM; Liachko NF; Kraemer BC
    Commun Biol; 2024 Jul; 7(1):903. PubMed ID: 39060347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTL-1 regulates neuronal integrity and lifespan in C. elegans.
    Chew YL; Fan X; Götz J; Nicholas HR
    J Cell Sci; 2013 May; 126(Pt 9):2079-91. PubMed ID: 23525010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UNG-1 and APN-1 are the major enzymes to efficiently repair 5-hydroxymethyluracil DNA lesions in C. elegans.
    Papaluca A; Wagner JR; Saragovi HU; Ramotar D
    Sci Rep; 2018 May; 8(1):6860. PubMed ID: 29717169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans.
    Han M; Saxton A; Currey H; Waldherr SM; Liachko NF; Kraemer BC
    Dis Model Mech; 2024 Mar; 17(3):. PubMed ID: 38469687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of Caenorhabditis elegans NTH, a homolog of human endonuclease III: essential role of N-terminal region.
    Morinaga H; Yonekura S; Nakamura N; Sugiyama H; Yonei S; Zhang-Akiyama QM
    DNA Repair (Amst); 2009 Jul; 8(7):844-51. PubMed ID: 19481506
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Pir GJ; Choudhary B; Mandelkow E
    FASEB J; 2017 Dec; 31(12):5137-5148. PubMed ID: 29191965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSUT2 is a determinant of susceptibility to tau neurotoxicity.
    Guthrie CR; Greenup L; Leverenz JB; Kraemer BC
    Hum Mol Genet; 2011 May; 20(10):1989-99. PubMed ID: 21355046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of Amyloid Beta (
    Sirwani N; Hedtke SM; Grant K; McColl G; Grant WN
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau.
    Brandt R; Gergou A; Wacker I; Fath T; Hutter H
    Neurobiol Aging; 2009 Jan; 30(1):22-33. PubMed ID: 17590239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOPA Decarboxylase Modulates Tau Toxicity.
    Kow RL; Sikkema C; Wheeler JM; Wilkinson CW; Kraemer BC
    Biol Psychiatry; 2018 Mar; 83(5):438-446. PubMed ID: 28751068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sut-6/NIPP1 modulates tau toxicity.
    Kow RL; Black AH; Henderson BP; Kraemer BC
    Hum Mol Genet; 2023 Jul; 32(14):2292-2306. PubMed ID: 37000013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of a tractable C. elegans model of tauopathy.
    Russell JC; Lei H; Chaliparambil RK; Fish S; Markiewicz SM; Lee TI; Noori A; Kaeberlein M
    Geroscience; 2021 Oct; 43(5):2621-2631. PubMed ID: 34536202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.